BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15077035)

  • 1. Critical evaluation of the amino acid triplet-epitope matching concept in cadaver kidney transplantation.
    Laux G; Mytilineos J; Opelz G
    Transplantation; 2004 Mar; 77(6):902-7. PubMed ID: 15077035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients.
    Duquesnoy RJ; Howe J; Takemoto S
    Transplantation; 2003 Mar; 75(6):889-97. PubMed ID: 12660520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival.
    Duquesnoy RJ; Takemoto S; de Lange P; Doxiadis II; Schreuder GM; Persijn GG; Claas FH
    Transplantation; 2003 Mar; 75(6):884-9. PubMed ID: 12660519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates.
    Duquesnoy RJ; Witvliet M; Doxiadis II; de Fijter H; Claas FH
    Transpl Int; 2004 Jan; 17(1):22-30. PubMed ID: 12955350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
    Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
    Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA amino acid residue matching.
    Takemoto SK
    Clin Transpl; 1996; ():397-425. PubMed ID: 9286585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The number of amino acid residues mismatches correlates with flow cytometry crossmatching results in high PRA renal patients.
    Lobashevsky AL; Senkbeil RW; Shoaf JL; Stephenson AK; Skelton SB; Burke RM; Deierhoi MH; Thomas JM
    Hum Immunol; 2002 May; 63(5):364-74. PubMed ID: 11975980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new epitope-based HLA-DPB matching approach for cadaver kidney retransplants.
    Laux G; Mansmann U; Deufel A; Opelz G; Mytilineos J
    Transplantation; 2003 May; 75(9):1527-32. PubMed ID: 12792509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm.
    Duquesnoy RJ
    Hum Immunol; 2002 May; 63(5):339-52. PubMed ID: 11975978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA compatibility and organ transplant survival. Collaborative Transplant Study.
    Opelz G; Wujciak T; Döhler B; Scherer S; Mytilineos J
    Rev Immunogenet; 1999; 1(3):334-42. PubMed ID: 11256424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deleterious impact of mismatching for human leukocyte antigen-C in presensitized recipients of kidney transplants.
    Tran TH; Döhler B; Heinold A; Scherer S; Ruhenstroth A; Opelz G
    Transplantation; 2011 Aug; 92(4):419-25. PubMed ID: 21743387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strength of HLA-A, HLA-B, and HLA-DR mismatches in relation to short- and long-term kidney graft survival. Collaborative Transplant Study.
    Opelz G
    Transpl Int; 1992; 5 Suppl 1():S621-4. PubMed ID: 14628741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class I amino acid sequence-based matching after interlocus subtraction and long-term outcome after deceased donor kidney transplantation.
    Kosmoliaptsis V; Sharples LD; Chaudhry A; Johnson RJ; Fuggle SV; Halsall DJ; Bradley JA; Taylor CJ
    Hum Immunol; 2010 Sep; 71(9):851-6. PubMed ID: 20538027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of human leucocyte antigen epitope matching using HLAMatchmaker for graft outcomes in a predominantly African-American renal transplant cohort.
    Haririan A; Fagoaga O; Daneshvar H; Morawski K; Sillix DH; El-Amm JM; West MS; Garnick J; Migdal SD; Gruber SA; Nehlsen-Cannarella S
    Clin Transplant; 2006; 20(2):226-33. PubMed ID: 16640531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the 1998 UK National Allocation Scheme for deceased heartbeating donor kidneys.
    Fuggle SV; Johnson RJ; Bradley JA; Rudge CJ;
    Transplantation; 2010 Feb; 89(4):372-8. PubMed ID: 20177337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes.
    Duquesnoy RJ; Marrari M
    Hum Immunol; 2002 May; 63(5):353-63. PubMed ID: 11975979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of amino acid mismatch in the UNOS dataset.
    Sasaki N; El-Awar N; Idica A
    Clin Transpl; 2011; ():299-309. PubMed ID: 22755423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of HLA matching for CREG antigens in Europe.
    Wujciak T; Opelz G
    Transplantation; 1999 Oct; 68(8):1097-9. PubMed ID: 10551635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA matching: identification of permissible HLA mismatches.
    Maruya E; Takemoto S; Terasaki PI
    Clin Transpl; 1993; ():511-20. PubMed ID: 7918185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.